E79 Disorders of purine and pyrimidine metabolism

Name of the Condition

• Disorders of Purine and Pyrimidine Metabolism (ICD-10 Code: E79)

Summary

Disorders of purine and pyrimidine metabolism are a group of genetic conditions affecting the body's ability to process nucleotides, which are essential for DNA and RNA synthesis. These disorders can lead to the accumulation of toxic metabolites or deficiencies in necessary compounds, resulting in a range of clinical manifestations. The severity and specific symptoms depend on the underlying enzymatic defect and its impact on metabolic pathways.

Causes

These disorders are caused by genetic mutations that disrupt enzymes involved in purine or pyrimidine metabolism. Inherited in an autosomal recessive or X-linked manner, they impair the breakdown or synthesis of nucleotides, leading to metabolic imbalances. The specific mutation determines the affected pathway and resulting clinical phenotype.

Risk Factors

• Family history of metabolic disorders.
• Consanguinity (increased risk in populations with shared ancestry).
• Ethnic or geographic prevalence of specific genetic variants.

Symptoms

• Neurological symptoms (e.g., developmental delay, seizures, intellectual disability).
• Gout or kidney stones (due to uric acid accumulation).
• Anemia or immune dysfunction (from impaired nucleotide synthesis).
• Skin lesions or photosensitivity (in some pyrimidine disorders).
• Growth retardation or failure to thrive.

Diagnosis

Diagnosis involves clinical evaluation, biochemical testing (e.g., measuring metabolite levels in blood or urine), and genetic testing to identify specific mutations. Enzyme activity assays may confirm the functional defect. Newborn screening is not universally available but may detect some disorders.

Treatment Options

Treatment focuses on managing symptoms and preventing complications. This may include dietary modifications (e.g., low-purine diets), medications to reduce metabolite accumulation (e.g., allopurinol for gout), and supportive therapies for neurological or developmental issues. Enzyme replacement or gene therapy is under investigation for some conditions.

Prognosis and Follow-Up

Prognosis varies widely depending on the specific disorder and severity. Early diagnosis and intervention can improve outcomes, but many conditions require lifelong management. Regular monitoring of metabolic markers, organ function, and developmental progress is essential to adjust treatment and address complications.

Complications

• Chronic kidney disease (from uric acid or oxalate accumulation).
• Neurological deterioration (if untreated or poorly managed).
• Increased risk of infections (due to immune dysfunction).
• Gout or joint damage (from hyperuricemia).

Lifestyle & Prevention

• Avoid triggers (e.g., high-purine foods, certain medications) as advised by a healthcare provider.
• Maintain hydration to support kidney function.
• Follow prescribed dietary or supplementation regimens.
• Genetic counseling for families with a history of these disorders.

When to Seek Professional Help

Seek medical attention for unexplained neurological symptoms, recurrent gout, kidney stones, or developmental delays. Prompt evaluation is critical for early diagnosis and intervention to prevent irreversible damage.

Tips for Medical Coders

Document the specific disorder (e.g., Lesch-Nyhan syndrome, adenine phosphoribosyltransferase deficiency) when available, as E79 is a broad category. Include details on metabolic testing, genetic confirmation, or clinical manifestations to support coding accuracy. Ensure documentation aligns with the specific enzymatic defect or clinical presentation for precise coding.